
The Acquisition of Pharma IT Will Enable PLG to Strengthen its Foothold in Northern Europe and Offer New Services in the Context of Life Sciences Digitilisation
Learn MoreWith the Acquisition of Quoretex, PLG Strengthens its Capabilities in Quality and Compliance
Learn MoreRegulatory Affairs
Regulatory operations
Product development
Quality & Compliance
Safety & Vigilance
Medical devices
04 august 2022
Small European based Research and Development company intending to develop and register their first NCE targeting Non-Alcoholic Fatty Liver Disease (NAFLD) & Steatohepatitis (NASH).
This drug was not authorised anywhere in the world.
Go to our Events to register
Go to our News to get insights